ARTICLE | Clinical News
Envirogen data
June 21, 1993 7:00 AM UTC
Ronald Unterman, vice president of R&D, told BioCentury that the cost of the technology, which will be determined by the size of the project, should be 50 percent to 75 percent less than the current a...